Prognosis and therapy of polymyositis/dermatomyositis.
Tuffanelli
D L
DL
Department of Medicine (Dermatology), University of California, San Francisco School of Medicine.
Lavoie
P E
PE
D000328:Adult; D000367:Age Factors; D002114:Calcinosis / Q000188:drug therapy / Q000209:etiology; D002648:Child; D003882:Dermatomyositis / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008875:Middle Aged; D009220:Myositis / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000150:complications / Q000401:mortality; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis
D007166:Immunosuppressive Agents; D011241:Prednisone